首页> 美国卫生研究院文献>Journal of Genomics >Isolation and Identification of an Anthracimycin Analogue from Nocardiopsis kunsanensis a Halophile from a Saltern by Genomic Mining Strategy
【2h】

Isolation and Identification of an Anthracimycin Analogue from Nocardiopsis kunsanensis a Halophile from a Saltern by Genomic Mining Strategy

机译:基因组采矿策略从昆士夜蛾嗜盐菌中分离出并鉴定出昆士夜蛾的炭疽霉素类似物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Modern medicine is unthinkable without antibiotics; yet, growing issues with microbial drug resistance require intensified search for new active compounds. Natural products generated by Actinobacteria have been a rich source of candidate antibiotics, for example anthracimycin that, so far, is only known to be produced by Streptomyces species. Based on sequence similarity with the respective biosynthetic cluster, we sifted through available microbial genome data with the goal to find alternative anthracimycin-producing organisms. In this work, we report about the prediction and experimental verification of the production of anthracimycin derivatives by Nocardiopsis kunsanensis, a non-Streptomyces actinobacterial microorganism. We discovered N. kunsanensis to predominantly produce a new anthracimycin derivative with methyl group at C-8 and none at C-2, labeled anthracimycin BII-2619, besides a minor amount of anthracimycin. It displays activity against Gram-positive bacteria with similar low level of mammalian cytotoxicity as that of anthracimycin.
机译:没有抗生素,现代医学是不可想象的。然而,微生物耐药性日益严重的问题要求人们对新的活性化合物的搜寻日益增加。由放线菌产生的天然产物已经是候选抗生素的丰富来源,例如迄今为止仅已知由链霉菌属物种产生的炭疽霉素。基于与各个生物合成簇的序列相似性,我们筛选了可用的微生物基因组数据,目的是寻找替代的生产蒽霉素的生物。在这项工作中,我们报告了非链霉菌放线菌微生物昆氏诺卡氏菌生产蒽霉素衍生物的预测和实验验证。我们发现昆山猪笼草主要生产一种新的炭疽霉素衍生物,其在C-8处具有甲基,而在C-2处则没有,被标记为炭疽霉素BII-2619,此外还有少量的炭疽霉素。它显示出对革兰氏阳性细菌的活性,而哺乳动物细胞毒性的水平与炭疽霉素相似。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号